Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 24, 2023

SELL
$77.31 - $88.08 $10,514 - $11,978
-136 Reduced 81.93%
30 $2,000
Q1 2023

May 23, 2023

BUY
$77.31 - $88.08 $10,514 - $11,978
136 Added 453.33%
166 $2,000
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $6,232 - $8,947
-100 Reduced 76.92%
30 $3,000
Q3 2022

Nov 08, 2022

BUY
$59.54 - $68.01 $7,740 - $8,841
130 New
130 $8,000
Q1 2022

May 02, 2022

SELL
$57.92 - $72.58 $7,529 - $9,435
-130 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$64.88 - $73.64 $9,926 - $11,266
-153 Reduced 54.06%
130 $9,000
Q3 2021

Nov 02, 2021

SELL
$67.69 - $73.03 $4,670 - $5,039
-69 Reduced 19.6%
283 $20,000
Q2 2021

Jul 28, 2021

BUY
$63.47 - $69.35 $6,347 - $6,934
100 Added 39.68%
352 $24,000
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $2,209 - $2,517
-39 Reduced 13.4%
252 $15,000
Q3 2020

Oct 13, 2020

BUY
$62.1 - $78.08 $18,071 - $22,721
291 New
291 $18,000
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $18,350 - $23,504
-293 Closed
0 $0
Q4 2019

Feb 21, 2020

SELL
$61.62 - $67.78 $16,575 - $18,232
-269 Reduced 47.86%
293 $19,000
Q3 2019

Oct 09, 2019

SELL
$62.51 - $69.0 $18,753 - $20,700
-300 Reduced 34.8%
562 $36,000
Q2 2019

Jul 16, 2019

SELL
$61.87 - $69.38 $27,532 - $30,874
-445 Reduced 34.05%
862 $58,000
Q1 2019

Apr 10, 2019

SELL
$62.53 - $70.05 $1,250 - $1,401
-20 Reduced 1.51%
1,307 $84,000
Q3 2018

Feb 08, 2019

BUY
$71.28 - $78.92 $94,588 - $104,726
1,327 New
1,327 $102,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Old North State Trust, LLC Portfolio

Follow Old North State Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old North State Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old North State Trust, LLC with notifications on news.